Please provide your email address to receive an email when new articles are posted on . In a cohort study based on the Pan-London PCI registry, patients who underwent OCT-guided PCI had improved ...

Please provide your email address to receive an email when new articles are posted on . Patients who underwent IVUS-guided PCI had more comorbidities but experienced less mortality, MI and repeat ...

Operators safely shaved a few minutes off heart attack reperfusion times by taking patients straight to culprit lesion percutaneous coronary intervention (PCI) when they arrived at the catheterization ...

MIAMI, FL — Use of coronary angiography and PCI after out-of-hospital cardiac arrest (OHCA) increased significantly over a 13-year period, according to new research [1]. However, "a significant ...

Rates of coronary angiography for patients with out-of-hospital cardiac arrest (OHCA) are similar across states with and without public reporting of PCI outcomes, according to a new study, but ...

ATLANTA -- The use of intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) in patients with acute coronary syndromes resulted in better outcomes compared with ...

MADRID, Spain—Routine use of CT angiography after PCI for left main coronary artery disease does not lower the risk of major adverse cardiac events, results of the PULSE trial show. There was a signal ...

Adding intravascular imaging to coronary angiography may not only sharpen placement of coronary stents, as shown in many studies, it may also reduce in-hospital clinical risk and boost long-term ...

ORLANDO – November 4, 2021 – The FAVOR III China trial found that lesion selection for percutaneous coronary intervention (PCI) using the non-invasively assessed physiologic measurement quantitative ...

Patients with CKD had twice the risk of target vessel failure after PCI compared with patients without CKD. The benefits of intravascular imaging-guided percutaneous coronary intervention (PCI) extend ...

Washington, D.C. – May 1, 2025 – New findings from FAVOR III China Trial, presented today as late-breaking science at the Society for Cardiovascular Angiography & Interventions (SCAI) 2025 Scientific ...